Stop by the #AACR26 poster on tumor and immune dynamics driving therapeutic resistance in SMARCB1-deficient renal medullary carcinoma by Kai Yu and colleagues @PavlosMsaouel and check out the results from the related phase II study, now. https://t.co/ayOzRxpdEE @UTMDAnderson https://t.co/Lbij6UQHFy